RPCEC00000177尚未招募1 期
Administration CIGB-500 in patients with acute myocardial infarction treated with primary coronary angioplasty.
Center for Genetic Engineering and Biotechnology (CIGB), in Havana0 个研究点目标入组 20 人开始时间: 2014年4月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Dose comparison. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 30 years 至 65 years（—）
- 性别
- All
入选标准
- •1) Compliance with the diagnostic criteria.
- •2) Patient presenting their first acute myocardial infarction (AMI).
- •3) Voluntary patient by providing their informed consent (oral).
排除标准
- •1) Cardiogenic shock as a presentation.
- •2) significant coronary multivessel disease.
- •3) Patients previously revascularized.
- •4) diabetics or with a history of pituitary adenoma patients.
- •5) Patients with a diagnosis of malignancy.
- •6) Pregnancy or lactation at the time of inclusion in the study (reported by the patient).
- •7) Mental incapacity apparent consent to issue and act accordingly to the study.
研究者
相似试验
已完成
1 期
CIGB500 in healthy volunteersHealthy volunteersHealthy VolunteersRPCEC00000017Center for Genetic Engineering and Biotechnology (CIGB), Havana City18
已完成
不适用
CIGB-258 at COVID-19COVID-19 respiratory distressCOVID-19SARS-CoV-2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusSevere Acute Respiratory SyndromeRPCEC00000313Center for Genetic Engineering and Biotechnology (CIGB), in Havana16
招募中
1 期
I-131MIBG therapy for the patients with newly diagnosed high-risk neuroblastomaneuroblastomaJPRN-jRCT2041190104Inaki Anri6
已完成
3 期
Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trialReumatoid Arthritis1000381610023213NL-OMON40517Boehringer Ingelheim2
进行中（未招募）
不适用
Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trialmoderately to severely active rheumatoid arthritisMedDRA version: 16.1Level: HLTClassification code 10039075Term: Rheumatoid arthritis and associated conditionsSystem Organ Class: 100000004870MedDRA version: 16.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2013-002622-23-NLBoehringer Ingelheim International GmbH250